loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2022_311___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Curia

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    SERVICES

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 CURIA SPAIN S.A.U. Boecillo ES (1)

    filter

    01 Medroxyprogesterone acetate (1)

    filter

    01 U.S.A (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    CURIA SPAIN S.A.U. Boecillo ES

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    • Audit Compliance
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Medroxyprogesterone acetate

    PDF Supplier PDF
    URL Supplier Web Content
    CEP 2022-311 - Rev 00
    Valid
    Chemical
    2024-01-26
    673
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for CEP 2022-311 - Rev 00 of Curia Spain S.a.u. Boecillo Es

    Looking for Certificates of Suitability (CEPs) for CEP 2022-311 - Rev 00 of Curia Spain S.a.u. Boecillo Es 1

    20

    Curia Spain S.a.u. Boecillo Es, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.

    One of their significant offerings is Medroxyprogesterone acetate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-311 - Rev 00

    This Chemical Type CEP, issued on January 26, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 673 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY